GILEAD SCIENCES, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 35146
 
 
 
C07D HETEROCYCLIC COMPOUNDS 25925
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 12917
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 8250
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 5448
 
 
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 5322
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 4155
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 3119
 
 
 
C07K PEPTIDES 29107
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 26112

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0071,302 SYK INHIBITORSSep 14, 17Mar 15, 18[A61K]
2018/0071,303 SYK INHIBITORSSep 14, 17Mar 15, 18[A61K]
2018/0065,938 TOLL LIKE RECEPTOR MODULATOR COMPOUNDSAug 31, 17Mar 08, 18[C07D, A61K]
2018/0065,953 PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORSAug 17, 17Mar 08, 18[C07D]
2018/0065,986 SODIUM (2R,5S,13AR)-7,9-DIOXO-10-((2,4,6-TRIFLUOROBENZYL)CARBAMOYL)-2,3,4,5,7,9,13,13A-OCTAHYDRO-2,5-METHANOPYRIDO[1',2':4,5]PYRAZINO[2,1-B][1,3]OXAZEPIN-8-OLATEJun 15, 17Mar 08, 18[C07D, A61K]
2018/0051,005 THERAPEUTIC COMPOUNDSAug 17, 17Feb 22, 18[C07F, C07D, C07C, A61K]
2018/0042,905 METHODS OF TREATING HEPATITIS B VIRUSAug 29, 17Feb 15, 18[A61K]
2018/0042,933 TREATMENT OF ACVR1-MEDIATED DISEASESAug 08, 17Feb 15, 18[A61K]
2018/0036,289 COBICISTAT FOR USE IN CANCER TREATMENTSAug 01, 17Feb 08, 18[A61K]
2018/0022,708 PROCESSES FOR PREPARING ASK1 INHIBITORSAug 17, 17Jan 25, 18[C07D]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9920018 Fused heterocyclic compounds as ion channel modulatorsDec 07, 16Mar 20, 18[C07D]
9907790 Solid forms of an ASK1 inhibitorApr 06, 17Mar 06, 18[C07D, A61K]
9908875 Apoptosis signal-regulating kinase inhibitorsDec 15, 14Mar 06, 18[C07D, A61K]
9891239 Modulators of pharmacokinetic properties of therapeuticsFeb 22, 08Feb 13, 18[C07D, A61K, G01N]
9878995 Cot modulators and methods of use thereofFeb 09, 17Jan 30, 18[C07D]
9879023 Therapeutic compoundsSep 06, 16Jan 30, 18[C07D, A61K]
9873680 Therapeutic compoundsAug 26, 15Jan 23, 18[C07D, A61K]
9873682 Apoptosis signal-regulating kinase inhibitorApr 19, 17Jan 23, 18[C07D, A61K]
9873716 Macrocyclic inhibitors of flaviviridae virusesJun 16, 15Jan 23, 18[C07D, A61K, C07K]
9862728 Crystalline forms of an antiviral compoundDec 21, 16Jan 09, 18[C07D, A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0197,985 SODIUM (2R,5S,13AR)-7,9-DIOXO-10-((2,4,6-TRIFLUOROBENZYL)CARBAMOYL)-2,3,4,5,7,9,13,13A-OCTAHYDRO-2,5-METHANOPYRIDO[1',2':4,5]PYRAZINO[2,1-B][1,3]OXAZEPIN-8-OLATEABANJun 19, 15Jul 13, 17[C07D, A61K]
2017/0190,708 PYRAZOLO[1,5-A]PYRIMIDINES FOR ANTIVIRAL TREATMENTABANNov 09, 16Jul 06, 17[C07D]
2017/0143,680 MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICSABANNov 01, 16May 25, 17[A61K]
2017/0136,000 METHOD OF TREATING A VIRAL INFECTION USING ELVITEGRAVIR COMBINATIONSABANOct 19, 16May 18, 17[A61K]
2017/0088,576 ANTIVIRAL COMPOUNDSABANSep 01, 16Mar 30, 17[C07H]
2017/0071,944 MODULATORS OF TOLL-LIKE RECEPTORS FOR THE TREATMENT OF HIVABANSep 13, 16Mar 16, 17[A61K]
2017/0065,592 MODULATORS OF TOLL-LIKE RECEPTORSABANAug 23, 16Mar 09, 17[A61K]
2017/0056,423 COMBINATION THERAPY COMPRISING TENOFOVIR ALAFENAMIDE HEMIFUMARATE AND COBICISTAT FOR USE IN THE TREATMENT OF VIRAL INFECTIONSABANOct 03, 16Mar 02, 17[A61K]
2017/0056,424 SOLID FORMS OF TENOFOVIRABANOct 05, 16Mar 02, 17[A61K]
2017/0029,427 COMPOUNDS AND METHODS FOR ANTIVIRAL TREATMENTABANJun 24, 16Feb 02, 17[C07D, A61K]
2017/0014,389 INHALABLE AZTREONAM LYSINATE FORMULATION FOR TREATMENT AND PREVENTION OF PULMONARY BACTERIAL INFECTIONSABANApr 19, 16Jan 19, 17[A61K]
2016/0362,416 ANTIVIRAL COMPOUNDSABANAug 24, 16Dec 15, 16[C07D, A61K]
2016/0346,280 COMPOSITIONS AND METHODS OF TREATING PULMONARY HYPERTENSIONABANAug 09, 16Dec 01, 16[A61K]
2016/0332,976 PROCESSES FOR PREPARING FUSED HETEROCYCLIC ION CHANNEL MODULATORSABANMay 02, 16Nov 17, 16[C07D]
2016/0332,977 PROCESSES FOR PREPARING FUSED HETEROCYCLIC ION CHANNEL MODULATORSABANMay 02, 16Nov 17, 16[C07D]
2016/0317,504 FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORSABANJul 07, 16Nov 03, 16[A61K]
2016/0303,088 MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICSABANMar 17, 16Oct 20, 16[A61K]
2016/0303,095 METHODS OF TREATING HEPATITIS B VIRUSABANApr 13, 16Oct 20, 16[A61K]
2016/0235,748 PYRAZOLO[1,5-A]PYRIMIDINES AS ANTIVIRAL AGENTSABANJan 19, 16Aug 18, 16[C07F, C07D, A61K]
2016/0220,633 MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSESABANApr 08, 16Aug 04, 16[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.